RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 1 year 18 weeks ago
Thu, 06/27/2024 - 02:00
Merck’s ADC Pact With Daiichi Hits Regulatory Setback in FDA Rejection 6/27/2024
Thu, 06/27/2024 - 02:00
Verona Wins FDA Approval for COPD Drug, Eyes Q3 Launch With $1B Financing for Rollout 6/27/2024
Thu, 06/27/2024 - 02:00
Novo Ends Phase III Kidney Disease Trial, Incurs More Than $800M Q2 Impairment Loss 6/27/2024
Thu, 06/27/2024 - 02:00
AbbVie, Genmab Secure FDA Label Expansion for Epkinly in Follicular Lymphoma 6/27/2024
Thu, 06/27/2024 - 02:00
CDC Narrows RSV Vaccine Recommendations for Seniors 6/27/2024
Thu, 06/27/2024 - 02:00
New Team, Same Company: How to Transition to Your New Role 6/27/2024
Thu, 06/27/2024 - 02:00
Leadership Lab: 3 Strategies for an Executive’s Discreet Job Search 6/27/2024
Thu, 06/27/2024 - 02:00
5 Top Companies Hiring in the Washington, D.C., Area 6/27/2024
Wed, 06/26/2024 - 02:00
Lyell Reports Patient Death in Early-Stage CAR T Trial, Shows Otherwise Strong Response Rate 6/26/2024
Wed, 06/26/2024 - 02:00
Zealand to Raise $1B in Public Offering to Fund Obesity Candidates 6/26/2024
Wed, 06/26/2024 - 02:00
Curie.Bio Adds $380M Series A Fund to Move Biotech Startups to Clinic 6/26/2024
Wed, 06/26/2024 - 02:00
Lilly Teams With OpenAI to Tackle Threat of Drug-Resistant Bacteria 6/26/2024
Wed, 06/26/2024 - 02:00
Wave Clears Phase Ib/IIa Study in Huntington’s Disease, Eyes Accelerated Approval 6/26/2024
Wed, 06/26/2024 - 02:00
Teva Pays $750M to Resolve Israeli Tax Issues Going Back More Than a Decade 6/26/2024
Wed, 06/26/2024 - 02:00
How Pfizer, Bristol Myers Squibb and Johnson & Johnson Are Confronting Patent Cliffs 6/26/2024
Wed, 06/26/2024 - 02:00
Sarepta’s Big DMD Approval, Alnylam’s Clinical Win and ADA Highlights 6/26/2024
Wed, 06/26/2024 - 02:00
After Full Approval, Sarepta Lays Out Its Next Moves 6/26/2024
Wed, 06/26/2024 - 02:00
Opinion: Prepare Your Biopharma for the Next Pandemic, for Business and Global Good 6/26/2024
Mon, 06/24/2024 - 02:00
5 FDA Decisions to Watch in the Second Half of 2024 6/24/2024
Mon, 06/24/2024 - 02:00
FDA Action Alert: Merck, Verona, AbbVie and Rocket 6/24/2024